Evidence map›Paper›PMID 40627326›Full record

ArticleObesity surgery2025

The Effect of Long Biliopancreatic Limb Versus Long Roux Versus Single Anastomosis Gastric Bypass: 5-Year Outcomes on HbA1c and Comorbidities.

Harbi Khalayleh, Izat Nazer, Loai Omari, George Asfour, Rafael Miller, Shimon Sapojnikov, Abed Khalaileh, Barak Bar-Zakai

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Harbi KhalaylehKaplan Medical Center, Rehovot, Israel. kraceve30@hotmail.com.
Izat NazerKaplan Medical Center, Rehovot, Israel.
Loai OmariKaplan Medical Center, Rehovot, Israel.
George AsfourKaplan Medical Center, Rehovot, Israel.
Rafael MillerKaplan Medical Center, Rehovot, Israel.
Shimon SapojnikovRabin Medical Center, Petah Tikva, Israel.
Abed KhalailehHebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel.
Barak Bar-ZakaiKaplan Medical Center, Rehovot, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study compared the outcomes of long biliopancreatic limb Roux-en-Y gastric bypass (GB) (LBP-RYGB), long Roux limb RYGB (LRL-RYGB), and one anastomosis gastric bypass (OAGB) regarding HbA1c level, glycemic control, and comorbidities improvement.

methodsRetrospective analysis of 257 bypass surgeries (2015-2018) divided into three groups based on the surgical technique: LBP-RYGB (n = 47), LRL-RYGB (n = 58), and OAGB (n = 152). Preoperative, operative, and postoperative data were collected and analyzed.

resultsOne-year weight loss was significantly higher in OAGB (40.45 ± 11.75 kg) as compared to LBP-RYGB (34.46 ± 14.07 kg) and LRL-RYGB (33.16 ± 10.86 kg), P = 0.002. One-year excessive body weight loss (EBWL) was 85.6% for LBP-RYGB, 79.9% for LRL-RYGB, and 90.4% for OAGB, P = .206. No significant differences were observed in final follow-up BMI (LBP-RYGB: 28.9 ± 4.36, LRL-RYGB: 29.6 ± 5.14, OAGB: 29.1 ± 3.61 kg/m

conclusionsAll three procedures effectively achieve weight loss and improve associated problems. However, OAGB had better 1-year weight loss, shorter operative time, and no internal hernia, making it an attractive option. RYGB should be reserved for reflux patients.

Indexed as

Biliopancreatic DiversionGastric BypassGlycated HemoglobinObesity, MorbidAdultComorbidityFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeWeight LossGlycated Hemoglobinhemoglobin A1c protein, humanComorbiditiesComplicationDeficiencyGastric bypassGlycemic controlMetabolic bariatric surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.